Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jiayan Li

Showing results (161-170 of 168) with videos related to

Pageof 17
Sort By:
You have reached the last page of results.This site can display upto 168 results.
Vaccines|May 25, 2024
Longitudinal Analysis of Humoral and Cellular Immune Response up to 6 Months after SARS-CoV-2 BA.5/BF.7/XBB Breakthrough Infection and BA.5/BF.7-XBB ReinfectionXun Wang, Meng Zhang, Kaifeng Wei, et al.
Scientific Reports|March 31, 2024
Efficacy and safety of radiofrequency ablation versus surgical sympathectomy in palmar hyperhidrosisYiyue Zhong, Yanwen Zhu, Jiayan Li, et al.
Communications Biology|March 6, 2025
Potent and broadly neutralizing antibodies against sarbecoviruses elicited by single ancestral SARS-CoV-2 infectionLei Yu, Yajie Wang, Yuanchen Liu, et al.
Cell Host & Microbe|November 29, 2023
Enhanced neutralization of SARS-CoV-2 variant BA.2.86 and XBB sub-lineages by a tetravalent COVID-19 vaccine boosterXun Wang, Shujun Jiang, Wentai Ma, et al.
Cell Discovery|February 6, 2024
Potent and broadly neutralizing antibodies against sarbecoviruses induced by sequential COVID-19 vaccinationXiaoyu Zhao, Tianyi Qiu, Xiner Huang, et al.
Nature Communications|November 26, 2025
Orphan broadly RBD-binding antibodies annotate three remaining conserved RBD epitopes along SARS-CoV-2 evolutionMinxiang Xie, Yinong Qiu, Xiaoyu Zhao, et al.
Nature Communications|December 11, 2025
Pathogenicity, virological features, and immune evasion of SARS-CoV-2 JN.1-derived variants including JN.1.7, KP.2, KP.3, and KP.3.1.1Jialu Shi, Xiaoyu Zhao, Xiaohui Jin, et al.
Nature Communications|October 8, 2024
Lineage-specific pathogenicity, immune evasion, and virological features of SARS-CoV-2 BA.2.86/JN.1 and EG.5.1/HK.3Yuanchen Liu, Xiaoyu Zhao, Jialu Shi, et al.
Pageof 17

Showing results (161-170 of 168) with videos related to

Sort By:
Pageof 17
You have reached the last page of results.This site can display upto 168 results.
Vaccines|May 25, 2024
Longitudinal Analysis of Humoral and Cellular Immune Response up to 6 Months after SARS-CoV-2 BA.5/BF.7/XBB Breakthrough Infection and BA.5/BF.7-XBB ReinfectionXun Wang, Meng Zhang, Kaifeng Wei, et al.
Scientific Reports|March 31, 2024
Efficacy and safety of radiofrequency ablation versus surgical sympathectomy in palmar hyperhidrosisYiyue Zhong, Yanwen Zhu, Jiayan Li, et al.
Communications Biology|March 6, 2025
Potent and broadly neutralizing antibodies against sarbecoviruses elicited by single ancestral SARS-CoV-2 infectionLei Yu, Yajie Wang, Yuanchen Liu, et al.
Cell Host & Microbe|November 29, 2023
Enhanced neutralization of SARS-CoV-2 variant BA.2.86 and XBB sub-lineages by a tetravalent COVID-19 vaccine boosterXun Wang, Shujun Jiang, Wentai Ma, et al.
Cell Discovery|February 6, 2024
Potent and broadly neutralizing antibodies against sarbecoviruses induced by sequential COVID-19 vaccinationXiaoyu Zhao, Tianyi Qiu, Xiner Huang, et al.
Nature Communications|November 26, 2025
Orphan broadly RBD-binding antibodies annotate three remaining conserved RBD epitopes along SARS-CoV-2 evolutionMinxiang Xie, Yinong Qiu, Xiaoyu Zhao, et al.
Nature Communications|December 11, 2025
Pathogenicity, virological features, and immune evasion of SARS-CoV-2 JN.1-derived variants including JN.1.7, KP.2, KP.3, and KP.3.1.1Jialu Shi, Xiaoyu Zhao, Xiaohui Jin, et al.
Nature Communications|October 8, 2024
Lineage-specific pathogenicity, immune evasion, and virological features of SARS-CoV-2 BA.2.86/JN.1 and EG.5.1/HK.3Yuanchen Liu, Xiaoyu Zhao, Jialu Shi, et al.
Pageof 17